UNSPSC 51162322: Acetaminophen/phenylpropanolamine/phenyltoloxamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162322 Acetaminophen/phenylpropanolamine/phenyltoloxamine is a Commodity code under which state and local governments procure pharmaceutical and over-the-counter products, though recent solicitations show the code capturing a broader range of health-system acquisitions including naloxone, drug deactivation systems, and generic multi-source pharmaceuticals distributed through authorized wholesalers and state cooperative purchasing frameworks. State and local issuing bodies using this code include county health departments (Seminole County, Florida) and state-led cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement). The scope extends from point-of-care acquisitions by individual counties—such as naloxone kits and drug disposal systems for community health facilities—to statewide and multi-state pharmaceutical commodity contracts that serve participating government agencies and their subordinate health-system facilities across multiple jurisdictions.

Recent activity concentrates in Florida and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a response deadline of July 26, 2023 and a two-year initial term plus one-year renewal option. MMCAP issued RFP S1070000015802 in January 2026, due March 26, 2026, to establish multiple-award contracts for generic multi-source pharmaceuticals and OTC products to be distributed through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC, with contract effectiveness targeted for July 1, 2026 and participating states including Oregon; the RFP weights price competitiveness at 75 percent and requires vendors to maintain compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, with a 3 percent administrative fee on all purchases.